Pharvaris N.V.
NASDAQ:PHVS
19.23 (USD) • At close January 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.252 | 0.15 | 0.08 | 0 | 0.001 | 0 |
| Gross Profit
| -0.252 | -0.15 | -0.08 | 0 | -0.001 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 65.575 | 57.376 | 35.789 | 19.508 | 5.685 | 3.645 |
| General & Administrative Expenses
| 31.139 | 29.339 | 18.349 | 5.498 | 2.326 | 0.668 |
| Selling & Marketing Expenses
| 0.2 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 31.339 | 29.339 | 18.349 | 5.498 | 2.326 | 0.668 |
| Other Expenses
| -0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 96.914 | 86.715 | 54.139 | 25.007 | 8.01 | 4.314 |
| Operating Income
| -96.914 | -86.738 | -65.899 | -25.013 | -7.993 | -4.314 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.913 | 11.084 | 11.478 | -1.062 | -0.017 | -0 |
| Income Before Tax
| -99.826 | -75.653 | -42.661 | -26.069 | -8.027 | -4.314 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.049 | 0.679 | 0.07 | -0.083 | 0.017 | 0 |
| Net Income
| -100.875 | -76.333 | -42.731 | -25.986 | -8.044 | -4.314 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.63 | -2.27 | -1.41 | -0.85 | -1.66 | -0.14 |
| EPS Diluted
| -2.63 | -2.27 | -1.41 | -0.85 | -1.66 | -0.14 |
| EBITDA
| -96.854 | -86.585 | -54.061 | -25.005 | -8.01 | -4.314 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |